Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer

Giuliani, J; Mantoan, B; Bonetti, A

Giuliani, J (通讯作者),Az ULSS 9 Scaligera, Dept Oncol, Via Gianella 1, I-37045 Legnago, VR, Italy.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (1): 199

Abstract

Recently, the introduction of encorafenib in combination with cetuximab was considered as a practice changing in BRAFV600-mutated metastatic colorecta......

Full Text Link